The specific relationship between vitamin D deficiency and diabetic nephropathy among patients with advanced chronic kidney disease: A cross-sectional study in Gran Canaria, Spain

Clinical Nephrology

Volumn 83, Issue 4, 2015, Pages 218-224

  Sánchez Hernández, Rosa M ^a   García Cantón, César ^a   Lorenzo, Dionisio L ^a   Virginia, Quevedo ^a   Bosch, Elvira ^a   López Ríos, Laura ^a   Riaño, Marta ^b   Boronat, Mauro ^a  

^a UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^b HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

Author keywords

Chronic; diabetic nephropathy; Kidney disease; Type 2 diabetes; vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; VITAMIN D;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHEMILUMINESCENCE IMMUNOASSAY; CHRONIC KIDNEY DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL EXAMINATION; PREVALENCE; PROTEIN URINE LEVEL; URINALYSIS; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; ANALOGS AND DERIVATIVES; BLOOD; COMPLICATION; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; HUMANS; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; SPAIN;

AGED; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; SPAIN; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84933043064     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN108446     Document Type: Article

References (29)

1. Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008; 87: 1080S-1086S. PubMed
2. Li YC. Vitamin D: roles in renal and cardiovascular protection. Curr Opin Nephrol Hypertens. 2012; 21: 72-79. CrossRef PubMed
3. Prentice A. Vitamin D deficiency: a global perspective. Nutr Rev. 2008; 66 ( Suppl 2): S153-S164. CrossRef PubMed
4. LaClair RE, Hellman RN, Karp SL, Kraus M, Ofner S, Li Q, Graves KL, Moe SM. Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am J Kidney Dis. 2005; 45: 1026-1033. CrossRef PubMed
5. Mehrotra R, Kermah D, Budoff M, Salusky IB, Mao SS, Gao YL, Takasu J, Adler S, Norris K. Hypovitaminosis D in chronic kidney disease. Clin J Am Soc Nephrol. 2008; 3: 1144-1151. CrossRef PubMed
6. Quarles LD. Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease. Exp Cell Res. 2012; 318: 1040-1048. CrossRef PubMed
7. Scragg R, Sowers M, Bell C; Third National Health and Nutrition Examination Survey. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care. 2004; 27: 2813-2818. CrossRef PubMed
8. Oh YJ, Park RW, Yoon D, Kim M, Han SS, Jang HR, Kim H, Heo NJ, Park SK, Lee H, Joo KW, Lim CS, Kim YS, Kim DK. Non-linear association of serum 25-hydroxyvitamin D with urinary albumin excretion rate in normoalbuminuric subjects. BMC Nephrol. 2014; 15: 97. CrossRef PubMed
9. Isakova T, Gutiérrez OM, Patel NM, Andress DL, Wolf M, Levin A. Vitamin D deficiency, inflammation, and albuminuria in chronic kidney disease: complex interactions. J Ren Nutr. 2011; 21: 295-302. CrossRef PubMed
10. Damasiewicz MJ, Magliano DJ, Daly RM, Gagnon C, Lu ZX, Ebeling PR, Chadban SJ, Atkins RC, Kerr PG, Shaw JE, Polkinghorne KR. 25-Hydroxyvitamin D levels and chronic kidney disease in the AusDiab (Australian Diabetes, Obesity and Lifestyle) study. BMC Nephrol. 2012; 13: 55.CrossRef PubMed
11. de Boer IH, Ioannou GN, Kestenbaum B, Brunzell JD, Weiss NS. 25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III). Am Kidney Dis. 2007; 50: 69-77. CrossRef PubMed
12. National Kidney Foundation. Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Available at: http://www.kidney.org/professionals/kdoqi/ guidelines_ckd/toc.htm. Accessed October 2014.
13. [2002 consensus document about the detection, prevention and treatment of diabetic nephropathy in Spain]. Nefrologia. 2002; 22: 521-530. PubMed
14. Instituto Nacional de Estadística (Statistics National Institute). Encuesta Nacional de Salud. Cuestionario de adultos (personas de 16 y más años). Available at: http://www.ine.es/metodologia/ t15/ens_adu06.pdf. Accessed October 2014.
15. Boronat M, García-Cantón C, Quevedo V, Lorenzo DL, López-Ríos L, Batista F, Riaño M, Saavedra P, Checa MD. Non-albuminuric renal disease among subjects with advanced stages of chronic kidney failure related to type 2 diabetes mellitus. Ren Fail. 2014; 36: 166-170. CrossRef PubMed
16. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM; Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96: 1911-1930. CrossRef PubMed
17. Ravani P, Malberti F, Tripepi G, Pecchini P, Cutrupi S, Pizzini P, Mallamaci F, Zoccali C. Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int. 2009; 75: 88-95. CrossRef PubMed
18. Figuiredo-Dias V, Cuppari L, Garcia-Lopes MG, de Carvalho AB, Draibe SA, Kamimura MA. Risk factors for hypovitaminosis D in nondialyzed chronic kidney disease patients. J Ren Nutr. 2012;22: 4-11. CrossRef PubMed
19. García-Cantón C, Bosch E, Auyanet I, Ramírez A,Rossique P, Culebras C, Sánchez A, Toledo A, Lago M, Esparza N, Checa MD. [25 hydroxyvitaminD levels and cardiovascular risk in a cohort of patients with advanced chronic kidney disease]. Nefrologia. 2010; 30: 435-442. PubMed
20. Jean G, Charra B, Chazot C. Vitamin D deficiency and associated factors in hemodialysis patients. J Ren Nutr. 2008; 18: 395-399. CrossRef PubMed
21. Navaneethan SD, Schold JD, Arrigain S, Jolly SE, Jain A, Schreiber MJ Jr, Simon JF, Srinivas TR, Nally JV Jr. Low 25-hydroxyvitamin D levels and mortality in non-dialysis-dependent CKD. Am J Kidney Dis. 2011; 58: 536-543. CrossRef PubMed
22. Mata-Granados JM, Luque de Castro MD, Quesada Gomez JM. Inappropriate serum levels of retinol, alpha-tocopherol, 25 hydroxyvitamin D3 and 24,25 dihydroxyvitamin D3 levels in healthy Spanish adults: simultaneous assessment byHPLC. Clin Biochem. 2008; 41: 676-680. Cross-Ref PubMed
23. Diaz VA, Mainous AG III, Carek PJ, Wessell AM, Everett CJ. The association of vitamin D deficiency and insufficiency with diabetic nephropathy: implications for health disparities. J Am Board Fam Med. 2009; 22: 521-527. CrossRef PubMed
24. Schmidt-Gayk H, Grawunder C, Tschöpe W, Schmitt W, Ritz E, Pietsch V, Andrassay K, Bouillon R. 25-hydroxy-vitamin-D in nephrotic syndrome. Lancet. 1977; 2: 105-108. CrossRef PubMed
25. Tanaka H, Hamano T, Fujii N, Tomida K, MatsuiI, Mikami S, Nagasawa Y, Ito T, Moriyama T, Horio M, Imai E, Isaka Y, Rakugi H. The impact of diabetes mellitus on vitamin D metabolism in predialysis patients. Bone. 2009; 45: 949-955. CrossRef PubMed
26. Thrailkill KM, Nimmo T, Bunn RC, Cockrell GE, Moreau CS, Mackintosh S, Edmondson RD, Fowlkes JL. Microalbuminuria in type 1 diabetes is associated with enhanced excretion of the endocytic multiligand receptors megalin and cubilin. Diabetes Care. 2009; 32: 1266-1268. CrossRef PubMed
27. Thrailkill KM, Jo CH, Cockrell GE, Moreau CS, Fowlkes JL. Enhanced excretion of vitamin D binding protein in type 1 diabetes: a role in vitamin D deficiency? J Clin Endocrinol Metab. 2011; 96: 142-149. CrossRef PubMed
28. Ogasawara S, Hosojima M, Kaseda R, Kabasawa H, Yamamoto-Kabasawa K, Kurosawa H, Sato H, Iino N, Takeda T, Suzuki Y, Narita I, Yamagata K, Tomino Y, Gejyo F, Hirayama Y, Sekine S, Saito A. Significance of urinary full-length and ectodomain forms of megalin in patients with type 2 diabetes. Diabetes Care. 2012; 35: 1112-1118. Cross- Ref PubMed
29. Klaus G. Renoprotection with vitamin D: specific for diabetic nephropathy? Kidney Int. 2008; 73: 141-143. CrossRef PubMed